Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 5 results.
User Information
Export Records
  1. 1.   Combinational delivery of TLR4 and TLR7/8 agonist enhanced the therapeutic efficacy of immune checkpoint inhibitors to colon tumor
  2. Wang, Mengjiao; Wan, Quan; Wang, Chenglv; Jing, Qianyu; Nie, Yujie; Zhang, Xiangyan; Chen, Xin; Yang,De; Pan, Runsang; Li, Linzhao; Zhu, Lan; Gui, Huan; Chen, Shuanghui; Deng, Yuezhen; Chen, Tao; Nie, Yingjie
  3. Molecular and Cellular Biochemistry. 2024, Mar 20;
  1. 2.   Regression and Eradication of Triple-Negative Breast Carcinoma in 4T1 Mouse Model by Combination Immunotherapies
  2. Nahar,Saifun; Huang,Yue; Nagy,Bethany; Zebala, John A; Maeda, Dean Y; Rudloff, Udo; Oppenheim, Joost J; Yang,De
  3. Cancers. 2023, Apr 19; 15(8):
  1. 3.   A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer
  2. Jiang, Mengmeng; Liu,Jia; Yang,De; Tross,Debra; Li, Ping; Chen, Fengyang; Alam,Md Masud; Faustman, Denise L; Oppenheim,Joost; Chen, Xin
  3. International immunopharmacology. 2021, Nov 15; 101(Pt A): 108345.
  1. 4.   HMGN1 and R848 Synergistically Activate Dendritic Cells Using Multiple Signaling Pathways
  2. Alam, Md Masud; Yang, De; Trivett, Anna; Meyer, Thomas; Oppenheim, Joost
  3. Frontiers in immunology. 2018, Dec 18; 9: 2982.
  1. 5.   Therapeutic vaccine to cure large mouse hepatocellular carcinomas.
  2. Han, Zhen; Yang, De; Trivett, Anna; Oppenheim, Joost
  3. Oncotarget. 2017, Aug 8; 8(32): 52061-52071.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel